Cleveland Clinic Abu Dhabi
Cleveland Clinic Abu Dhabi is a 364-bed tertiary and quaternary multispecialty hospital on Al Maryah Island, serving UAE residents and international medical tourists from across the GCC, South Asia, and beyond with complex procedures, transplants, oncology, and AI-augmented diagnostics as part of the M42 group under a Mubadala-Cleveland Clinic joint venture.
- Company typePrivate
- Founded2015
- HeadquartersAbu Dhabi, United Arab Emirates
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Cleveland Clinic Abu Dhabi does
Cleveland Clinic Abu Dhabi is a 364-bed (expandable to 490) multispecialty tertiary and quaternary hospital on Al Maryah Island in Abu Dhabi, operating as part of the M42 group under a joint venture between Mubadala Investment Company and Cleveland Clinic (US), established through a 2006 agreement and opened in 2015. The hospital delivers care across 50+ medical and surgical specialties organized into eight institutes (Cancer/Fatima bint Mubarak Center, Diagnostics, Digestive Disease, Heart Vascular & Thoracic, Neurological, Integrated Surgical, Medical Specialty, and Integrated Hospital Care), supplemented by the Executive Health Program and UAE's first and only multi-organ transplant center, with 800+ transplants performed in under a decade and nearly 10,000 complex procedures in 2025.
The underlying technology stack includes AI-powered clinical decision support (Aila, co-developed with Owkin as the world's first clinical AI scientist using natural language processing across EHRs, pathology, imaging, and physician notes), computer vision-based diagnostics (Qritive for prostate cancer pathology, FLAIRstar for multiple sclerosis MRI), an AI-driven surgical intelligence network (Johnson & Johnson's Polyphonic with AWS and NVIDIA), robotic-assisted surgical systems for minimally invasive procedures including lung transplants and remote kidney telesurgery, and AI-powered multi-cancer early detection with genomic sequencing for biomarker-driven therapy.
Revenue is generated through patient care services billed via direct pay, insurance partnerships (Aafiya, Adnic, Aetna, Axa, Daman, Damana, among others), and corporate channels. Go-to-market combines direct-to-consumer medical tourism (35% international patient volume growth in 2024 across Kuwait, Saudi Arabia, Pakistan, Bahrain, and USA), exclusive digital distribution partnerships (DAWI in Kuwait for Executive Health Program), professional referrals, and government/ecosystem partnerships with the Department of Health Abu Dhabi. Strategic positioning emphasizes serving patients across the GCC and wider region who would otherwise travel abroad for complex care, supported by JCI, Magnet, ACCME, and CAP accreditations and five consecutive years as the top-ranked Smart Hospital in the UAE and GCC by Newsweek.
Cleveland Clinic Abu Dhabi firmographics
Firmographics- Name
- Cleveland Clinic Abu Dhabi
- Legal name
- Cleveland Clinic Abu Dhabi LLC
- Website
- https://clevelandclinicabudhabi.ae
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Cleveland Clinic Abu Dhabi is a 364-bed tertiary and quaternary multispecialty hospital on Al Maryah Island, serving UAE residents and international medical tourists from across the GCC, South Asia, and beyond with complex procedures, transplants, oncology, and AI-augmented diagnostics as part of the M42 group under a Mubadala-Cleveland Clinic joint venture.
- Ownership category
- akta.pro rank
Cleveland Clinic Abu Dhabi industry classification
Industry- Product category
- Multispecialty Hospital Services
- NAICS
- General Medical and Surgical Hospitals (62211)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Where Cleveland Clinic Abu Dhabi is headquartered
LocationHeadquarters
- HQ city
- Abu Dhabi
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
Cleveland Clinic Abu Dhabi business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Patient Care Services: Tertiary and quaternary healthcare services including complex surgical procedures, transplants, cancer care, and executive health programs. Revenue generated through direct patient billing, insurance claims, and self-pay arrangements.
- International Patient Services: Cross-border healthcare services attracting medical tourists with 35% growth in international patient volume. Services include comprehensive diagnostic workups, treatment programs, and concierge support for international patients.
- Executive Health Program: Comprehensive health check-up programs and preventive medicine services for individuals and corporate clients, including partnership with DAWI for Kuwaiti market access.
- Clinical Trials and Research: Research and innovation activities including clinical trials conducted in partnership with global pharmaceutical and biotech companies, supported by Department of Health funding.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Comprehensive Health Check-up |
| Other | Pay-as-you-go | Self-Pay and Insurance Billing |
Go-to-market motion4 records
Distribution channels7 records
Marketing channels8 records
Cleveland Clinic Abu Dhabi product offering
Product offeringCore offering
Cleveland Clinic Abu Dhabi is a multispecialty tertiary and quaternary hospital on Al Maryah Island, Abu Dhabi, providing advanced medical and surgical care across multiple clinical institutes, including cancer, cardiac, neurological, digestive disease, and integrated surgical services. The hospital performs complex procedures such as organ transplantation, robotic surgery, and AI-assisted diagnostics, and functions as a regional referral center serving patients in the UAE and the wider Middle East.
Product overview
Cleveland Clinic Abu Dhabi is a 411-bed multispecialty hospital on Al Maryah Island in Abu Dhabi, offering care across 50+ medical and surgical specialties through 8 dedicated institutes. The hospital operates a platform-plus-specialty model with its core institutes (Cancer Institute/Fatima bint Mubarak Center, Diagnostics Institute, Digestive Disease Institute, Heart & Thoracic Institute, Neurological Institute, Integrated Surgical Institute, Medical Specialty Institute, and Integrated Hospital Care Institute) providing comprehensive care, supplemented by specialized programs including the Executive Health Program, Abdominal Transplant Program, and Multidisciplinary Simulation Center. Recent innovations include the Aila clinical AI scientist platform and AI-powered prostate cancer diagnostics through the Diagnostics Institute.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Institute (Fatima bint Mubarak Center)
Quantifiable outcome
- 35% growth in international patient volume with over 10,000 international patient encounters
- +6 more outcomes
Companies that use Cleveland Clinic Abu Dhabi
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles2 records
Cleveland Clinic Abu Dhabi technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability10 records
Feature9 records
Cleveland Clinic Abu Dhabi partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- OwkincoreCollaboration to launch 'Aila,' the world's first clinical AI scientist, designed to support real-time clinical decision-making and accelerate medical research using real patient data. The AI platform uses natural language processing to query vast amounts of clinical data and deliver insights that previously required days or weeks of manual analysis. Initial deployment focuses on prostate cancer, with plans to scale across additional medical specialities.
- NYU Abu DhabiminorJoint research with NYU Abu Dhabi to develop injectable wireless medical device capable of controlling nerve activity without surgery, batteries, or wires. The device, roughly the size of a small seed, can be injected near a target nerve and delivers programmable electrical stimulation powered wirelessly, allowing real-time adjustment.
- QritivecorePartnership between M42's National Reference Laboratory and Qritive to introduce AI-powered prostate cancer diagnostics in the UAE, integrated into Cleveland Clinic Abu Dhabi's diagnostic workflow. The platform analyzes digital pathology slides to help detect prostate cancer, assess tumor patterns, and support grading according to internationally recognised standards.
- Johnson & JohnsoncoreCollaboration with Department of Health Abu Dhabi to launch global surgical intelligence network using Johnson & Johnson's Polyphonic digital ecosystem. The initiative integrates technology partners AWS and NVIDIA to deploy AI-powered surgical tools across operating rooms, connecting hospitals including Cleveland Clinic Abu Dhabi to capture surgical video and multimodal data for AI development. Abu Dhabi serves as first node in worldwide infrastructure for AI-driven surgical innovation.
- M42's IROS DivisioncoreOversees clinical operations for UAE's first clinical trial for gene therapy targeting MerTK-related retinitis pigmentosa. The trial, developed by Opus Genetics, is funded by Authority of Social Contribution Ma'an with clinical development activities expected to commence in 2026.
- Opus GeneticsminorClinical trial evaluating OPGx-MERTK gene therapy for MERTK-related retinitis pigmentosa conducted at Cleveland Clinic Abu Dhabi. Trial funded through Abu Dhabi's Healthcare Research and Innovation Fund, supported by Department of Health Abu Dhabi, M42's IROS division, and Authority of Social Contribution Ma'an. Positions Abu Dhabi as hub for precision medicine.
- DAWIcoreDAWI serves as exclusive digital partner for Cleveland Clinic Abu Dhabi's Executive Health Program in the Kuwaiti market. The partnership enables users in Kuwait to search, book, and manage executive health services delivered in Abu Dhabi through a digital platform. Later phases may extend to additional medical specialties and services.
- Department of Health Abu DhabicoreLicensing and regulatory partnership as designated research and teaching facility. Department of Health supports clinical trials and innovation initiatives including intelligent surgical network and gene therapy trials. Also provides designations as Teaching Hospital, Official Stroke Center, and Centre of Excellence for Adult Cardiac Surgery.
- Archer AviationminorPartnership to develop UAE's first hospital-based vertiport for electric air taxi access using Archer's Midnight eVTOL aircraft. The vertiport would serve both non-emergency passenger transport and time-critical organ transport, with upgrade of existing helipad infrastructure to enable both traditional helicopter and eVTOL operations.
- NYU Abu Dhabi, Yas Clinic Khalifa City, Abu Dhabi Stem Cells CenterminorCollaboration to develop FLAIRstar, an AI-powered MRI analysis technique for Multiple Sclerosis diagnosis. The tool automatically detects the central vein sign in brain lesions using LAMINATE project methodology supported by National MS Society. All patient data secured within UAE.
- Cleveland Clinic (US)coreCleveland Clinic Abu Dhabi is extension of Cleveland Clinic model of care, providing access to world-class clinical practices, research methodologies, and global best practices. Modeled on Cleveland Clinic's Taussig Cancer Center and other renowned institutes.
Scale indicators16 records
Recent moves6 records
Expansion highlights6 records
Cleveland Clinic Abu Dhabi competitors and assessment
Company assessmentDirect peers
- Saudi German Hospital Group: Largest private hospital group in MENA region with multi-specialty tertiary hospitals. Competes for medical tourism across GCC and offers similar complex care capabilities in the region.
- Mediclinic Middle East: Operates multi-specialty hospitals across UAE with similar premium positioning and international patient services. Directly competes with CCAD for medical tourism volume and complex care referrals in the region.
- NMC Healthcare: Largest private healthcare provider in UAE with multi-specialty hospitals serving similar patient demographics. Competes on complex care and is a participant in Abu Dhabi's intelligent surgical network.
- Healthpoint Abu Dhabi: Multi-specialty hospital in Abu Dhabi operated as part of M42 network. Competes within same geography for complex care cases and participates in similar government partnerships.
- King's College Hospital London (Dubai): International brand-affiliated multi-specialty hospital in UAE with similar positioning as a UK-branded tertiary care destination. Competes for international patients and complex case referrals.
- Burjeel Hospital: UAE-based multi-specialty hospital group with premium positioning and complex care services. Direct competitor in Abu Dhabi and broader UAE market for tertiary/quaternary care.
- American Hospital Dubai: Multi-specialty tertiary hospital in UAE with US-affiliated physicians and similar premium/complex care positioning. Competes for international patients and complex cases across similar specialties.
Regional players
- King Faisal Specialist Hospital and Research Centre: Saudi Arabia's premier tertiary/quaternary hospital and research center. Competes for regional complex care patients across GCC, particularly for oncology, transplant, and genetic medicine cases.
- Sidra Medicine: Qatar-based specialty hospital affiliated with Weill Cornell with similar premium positioning and complex care focus. Competes for GCC medical tourism market, particularly for women's and pediatric specialty services.
Broad incumbents
- Cleveland Clinic (US): Parent brand and operator providing clinical model, protocols, and physician expertise to CCAD. Comparable as a global multi-specialty academic medical center with similar specialty institutes and research orientation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Cleveland Clinic Abu Dhabi social profiles
Digital presenceCleveland Clinic Abu Dhabi compliance and trust
Trust signalCompliance9 records
Cleveland Clinic Abu Dhabi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cleveland Clinic Abu Dhabi leadership team
Management profileNumber of profiles
Profiles2 records
Cleveland Clinic Abu Dhabi funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cleveland Clinic Abu Dhabi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cleveland Clinic Abu Dhabi
What does Cleveland Clinic Abu Dhabi do?
Cleveland Clinic Abu Dhabi is a multispecialty tertiary and quaternary hospital on Al Maryah Island, Abu Dhabi, providing advanced medical and surgical care across multiple clinical institutes, including cancer, cardiac, neurological, digestive disease, and integrated surgical services. The hospital performs complex procedures such as organ transplantation, robotic surgery, and AI-assisted diagnostics, and functions as a regional referral center serving patients in the UAE and the wider Middle East.
Is Cleveland Clinic Abu Dhabi a public or private company?
Cleveland Clinic Abu Dhabi is a private company. It is classified as corporate owned and is currently operating.
When was Cleveland Clinic Abu Dhabi founded?
Cleveland Clinic Abu Dhabi was founded in 2015. It employs 1,001 to 5,000 people.
Where is Cleveland Clinic Abu Dhabi based?
Cleveland Clinic Abu Dhabi is headquartered in Abu Dhabi, United Arab Emirates, in the Middle East region.
How does Cleveland Clinic Abu Dhabi make money?
Four revenue lines are on record. Patient Care Services are the primary driver. The others are international Patient Services, executive Health Program and clinical Trials and Research.
Who are Cleveland Clinic Abu Dhabi's main competitors?
Direct peers on record are Saudi German Hospital Group, Mediclinic Middle East, NMC Healthcare, Healthpoint Abu Dhabi, King's College Hospital London (Dubai), Burjeel Hospital and American Hospital Dubai. Regional players are King Faisal Specialist Hospital and Research Centre and Sidra Medicine. Cleveland Clinic (US) is listed as a broad incumbent.
Does Cleveland Clinic Abu Dhabi have an API?
No public API is recorded for Cleveland Clinic Abu Dhabi.
What industry is Cleveland Clinic Abu Dhabi in?
Cleveland Clinic Abu Dhabi's product category is Multispecialty Hospital Services. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 62211 and its SIC code is 8062.